Name: 1,4-DPCA
Price: 255.00 USD

- Overview
  - Please contact us at for specific academic pricing.
    
    Background
    
    1,4-DPCA is a competitive inhibitor of prolyl 4-hydroxylase with IC50 value of 3.6 μM [1].Prolyl hydroxylase catalyzes the formation of hydroxyproline, which has a significant impact on the stability of collagen- the major connective tissue of the human body. Increased collagen deposition produces physical and biochemical signals to sustain tumor growth, resulting in tumor invasion and development. Therefore, 1,4-DPCA has been considered as a treatment strategy to suppress cancer progression as it inhibits collagen synthesis and deposition. The suppression effect of 1,4-DPCA had been shown in human breast cancer cells. The activity of prolyl-4-hydroxylase was inhibited by 1, 4-DPCA, resulting in decreased deposition of collagen I and IV. In breast tumor cell lines ZR-75-1, T4-2, MDA-MB-157 and MDA-MB-231, treatment with 1,4-DPCA reduced cell proliferation and colony sizes, and formed smaller and less aggressive structures of these four cell lines[2].
    
    [1]. T. J. Franklin, W. P. Morris, P. N. Edwards, et al. Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. Biochemistry Journal 353, 333-338 (2001).
    [2]. Xiong G, Deng L, Zhu J, et al. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer, 2014 Jan 2; 14:1.
- Properties
  - Alternative Name
    
    1,4-dihydrophenonthrolin-4-one-3-Carboxylic acid; 4,4α-dihydro-4-oxo-1,10-phenanthroline-3-carboxylic acid
    
    CAS Number
    
    331830-20-7
    
    Molecular Formula
    
    C13H8N2O3
    
    Molecular Weight
    
    240.2
    
    Appearance
    
    A crystalline solid
    
    Purity
    
    98.00%
    
    Solubility
    
    ≤3mg/ml in DMSO;3mg/ml in dimethyl formamide
    
    Storage
    
    Store at -20°C
    
    * For Research Use Only

1,4-DPCA

1,4-DPCA

Background

We Also Recommend

DL-α-Difluoromethylornithine (hydrochloride hydrate)

EGFR Inhibitor

MI-2 (hydrochloride)